IceCure Medical

IceCure Medical is an innovative medical device company (NASDAQ: ICCM) founded with the mission to improve minimally invasive treatment for benign and cancerous tumors by freezing them. Its flagship liquid nitrogen cryoablation technology enables a fast and convenient procedure with outstanding results, minimal pain, rapid recovery and fewer complications compared to more invasive surgeries. The company's ProSense Cryoablation System has received FDA clearance for the local treatment of low-risk breast cancer in patients aged 70 and older.

IceCure Medical is an innovative medical device company (NASDAQ: ICCM) founded with the mission to improve minimally invasive treatment for benign and cancerous tumors by freezing them. The company's ProSense Cryoablation System has received FDA clearance for the local treatment of low-risk breast cancer in patients aged 70 and older.

• ProSense Cryoablation System

  A liquid nitrogen cryoablation system that freezes and destroys tumors by creating an ice ball around the targeted tissue.

• 2021.12.20

  Reported2021.12.20

  IceCure receives notice of intention to grant European patent[4]IceCure 收到欧洲专利授权意向通知prnewswire.com

  IceCure Medical announced that the European Patent Office notified it of an intention to grant a patent for its “Cryogen Pump” application. The patent had not yet been issued.

• 2021.12.09

  Reported2021.12.09

  IceCure Medical prices $15 million public offering[5]IceCure Medical 为 1,500 万美元公开发行定价prnewswire.com

  IceCure Medical announced pricing for an underwritten public offering of ordinary shares and pre-funded warrants. The company said gross proceeds were expected to be approximately $15 million, before offering expenses; closing was expected on or about December 13, 2021.

• Unconfirmed

  Reported2021.09.23

  IceCure expands ProSense distribution network[6]IceCure扩大ProSense分销网络prnewswire.com

  IceCure reported expanding the ProSense distribution network, adding exclusive sales arrangements in Turkey and Brazil, a distributor in parts of India, and Thailand to its distribution partnership with Terumo, which already covered Japan and Singapore.

• 2021.09.23

  Reported2021.09.23

  IceCure reports first-half 2021 financial results[6]IceCure扩大ProSense分销网络prnewswire.com

  IceCure Medical reported its financial results for the six-month period ended June 30, 2021. It reported revenue of approximately $2.1 million and a net loss of approximately $3.8 million for the period.

• 2021.02.17

  Reported2021.02.17

  IceCure announces exclusive distribution agreement with Rise General Trading[7]IceCure 宣布与 Rise General Trading 达成独家分销协议prnewswire.com

  IceCure announced an exclusive distribution agreement with Rise General Trading for the ProSense Cryoablation System in the United Arab Emirates and Arabian Gulf States. The agreement is for three years.

• 2020.10.05

  Reported2020.10.05

  IceCure and Terumo announce expanded distribution partnership in Thailand[8]IceCure与Terumo宣布扩大在泰国的分销合作prnewswire.com

  IceCure Medical announced an expanded partnership with Terumo under which Terumo is expected to receive exclusive rights to distribute IceCure products in Thailand for six years; the agreement was expected to be finalized by year-end.

• 2020.04.22

  Reported2020.04.22

  IceCure signs exclusive German distribution agreement with MTS Medical Technology[9]IceCure与MTS Medical Technology签署德国独家经销协议prnewswire.com

  IceCure Medical entered into an exclusive distribution agreement with MTS Medical Technology to commercialize its ProSense cryoablation system and consumables in Germany. The agreement calls for MTS Medical to purchase a minimum of EUR 375,000 in products and consumables by the end of March 2021.

• 2019.12.02

  Reported2019.12.02

  IceCure Medical appoints Sharon Levita to its board[10]IceCure Medical任命Sharon Levita为董事会成员prnewswire.com

  IceCure Medical announced the appointment of Sharon Levita to its board of directors, increasing the board to six members.

Read more

1. 1Cryoablation: a less invasive choice for tumor destruction | IceCureicecure-medical.com
2. 2About Us - IceCureicecure-medical.com
3. 3Medical Device Careers | IceCureicecure-medical.com
4. 4IceCure 收到欧洲专利授权意向通知prnewswire.com
5. 5IceCure Medical 为 1,500 万美元公开发行定价prnewswire.com
6. 6IceCure扩大ProSense分销网络prnewswire.com
7. 7IceCure 宣布与 Rise General Trading 达成独家分销协议prnewswire.com
8. 8IceCure与Terumo宣布扩大在泰国的分销合作prnewswire.com
9. 9IceCure与MTS Medical Technology签署德国独家经销协议prnewswire.com
10. 10IceCure Medical任命Sharon Levita为董事会成员prnewswire.com